Scilex Holding Company
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−33.0787 USD
−72.81 M USD
56.59 M USD
7.01 M
About Scilex Holding Company
Sector
Industry
CEO
Henry H. Ji
Website
Headquarters
Palo Alto
Founded
2020
Identifiers
3
ISIN US80880W1146
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Displays a symbol's price movements over previous years to identify recurring trends.